These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32028062)

  • 1. Novel pyrazine based anti-tubercular agents: Design, synthesis, biological evaluation and in silico studies.
    Hassan NW; Saudi MN; Abdel-Ghany YS; Ismail A; Elzahhar PA; Sriram D; Nassra R; Abdel-Aziz MM; El-Hawash SA
    Bioorg Chem; 2020 Mar; 96():103610. PubMed ID: 32028062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2-Aminoaryl-3,5-diaryl pyrazines: Synthesis, biological evaluation against Mycobacterium tuberculosis and docking studies.
    Gangarapu NR; Ranganatham A; Reddy EK; Yellappa S; Chandrasekhar KB
    Arch Pharm (Weinheim); 2020 Jul; 353(7):e1900368. PubMed ID: 32399980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification.
    Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B
    Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids.
    Semelková L; Janošcová P; Fernandes C; Bouz G; Janďourek O; Konečná K; Paterová P; Navrátilová L; Kuneš J; Doležal M; Zitko J
    Molecules; 2017 Sep; 22(9):. PubMed ID: 28880230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of carbohydrazides and carboxamides as anti-tubercular agents.
    Kumar G; Krishna VS; Sriram D; Jachak SM
    Eur J Med Chem; 2018 Aug; 156():871-884. PubMed ID: 30056283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-Pot Synthesis of Novel Hydrazono-1,3-Thıazolıdın-4-One Derivatives as Anti-HIV and Anti-Tubercular Agents: Synthesıs, Bıologıcal Evaluatıon, Molecular Modelling and Admet Studıes.
    Pasha MA; Mondal S; Panigrahi N; Shetye G; Ma R; Franzblau SG; Zheng YT; Murugesan S
    Curr HIV Res; 2022; 20(3):255-271. PubMed ID: 35549861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and antimycobacterial evaluation of novel adamantane and adamantanol analogues effective against drug-resistant tuberculosis.
    Alsayed SSR; Lun S; Payne A; Bishai WR; Gunosewoyo H
    Bioorg Chem; 2021 Jan; 106():104486. PubMed ID: 33276981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
    Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and synthesis of novel inhibitors of mycobacterium ATP synthase.
    Surase YB; Samby K; Amale SR; Sood R; Purnapatre KP; Pareek PK; Das B; Nanda K; Kumar S; Verma AK
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3454-3459. PubMed ID: 28587823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, biological evaluation and structure-activity relationship of 2-styrylquinazolones as anti-tubercular agents.
    Jadhavar PS; Dhameliya TM; Vaja MD; Kumar D; Sridevi JP; Yogeeswari P; Sriram D; Chakraborti AK
    Bioorg Med Chem Lett; 2016 Jun; 26(11):2663-9. PubMed ID: 27095514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, In silico and In vitro Analysis of Hydrazones as Potential Antituberculosis Agents.
    Thorat BR; Mali SN; Rani D; Yamgar RS
    Curr Comput Aided Drug Des; 2021; 17(2):294-306. PubMed ID: 32141422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ureidopyrazine Derivatives: Synthesis and Biological Evaluation as Anti-Infectives and Abiotic Elicitors.
    Bouz G; Juhás M; Niklová P; Janďourek O; Paterová P; Janoušek J; Tůmová L; Kovalíková Z; Kastner P; Doležal M; Zitko J
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29065539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates.
    Ribeiro RCB; de Marins DB; Di Leo I; da Silva Gomes L; de Moraes MG; Abbadi BL; Villela AD; da Silva WF; da Silva LCRP; Machado P; Bizarro CV; Basso LA; Cristina de Moraes M; Ferreira VF; da Silva FC; Nascimento V
    Eur J Med Chem; 2021 Jan; 209():112859. PubMed ID: 33010635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hybrids of thienopyrimidinones and thiouracils as anti-tubercular agents: SAR and docking studies.
    Pisal MM; Nawale LU; Patil MD; Bhansali SG; Gajbhiye JM; Sarkar D; Chavan SP; Borate HB
    Eur J Med Chem; 2017 Feb; 127():459-469. PubMed ID: 28103537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis.
    Chitre TS; Asgaonkar KD; Miniyar PB; Dharme AB; Arkile MA; Yeware A; Sarkar D; Khedkar VM; Jha PC
    Bioorg Med Chem Lett; 2016 May; 26(9):2224-8. PubMed ID: 27017114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, Characterization, 'ADMET-SAR' Prediction, DPPH Assay, and Anti-Mycobacterium Study of 4-[(substituted benzyl) amino]benzo hydrazides and its Hydrazones as the Acyl-CoA Carboxylase, AccD5 Inhibitors.
    Desale VJ; Mali SN; Thorat BR; Yamgar RS; Dharanguttikar SV; Dharanguttikar VR; Chtita S; Oliveira M; Cruz JN
    Curr Comput Aided Drug Des; 2023; 19(4):300-312. PubMed ID: 36578253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-pot synthesis, spectral characterization, biological evaluation, molecular docking studies and in silico ADME/Tox profiling of new 2,4,5 triaryl imidazole derivatives as anti tubercular agents.
    Munnaluri RK; Chevula J; Patnam N; Yamini L; Manga V
    Indian J Tuberc; 2023 Oct; 70(4):451-459. PubMed ID: 37968051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of benzo[d]imidazole-2-carboxamides as new anti-TB agents.
    Dhameliya TM; Patel KI; Tiwari R; Vagolu SK; Panda D; Sriram D; Chakraborti AK
    Bioorg Chem; 2021 Feb; 107():104538. PubMed ID: 33349456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Alkylamino-
    Ambrożkiewicz W; Kučerová-Chlupáčová M; Janďourek O; Konečná K; Paterová P; Bárta P; Vinšová J; Doležal M; Zitko J
    Molecules; 2020 Mar; 25(7):. PubMed ID: 32231166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.